EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Improving the hemocompatibility of centrifugal mechanical circulatory support devices at low flow rates

Mathieu Specklin iD, Louis Marcel, Navideh Abbasnezhad iD, Farid Bakir, Smaine Kouidri, Pichoy Danial

Artificial Organs · 2025

DOI: 10.1111/aor.14899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Mathieu Specklin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cnam, Arts et Metiers Institute of Technology, LIFSE, Paris, France. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An innovative solution has been recently proposed for the treatment of heart failure with preserved ejection fraction (HFpEF), using a centrifugal mechanical circulatory support (MCS) device. We sought firstly to assess the hemocompatibility of the proposed device. HFpEF treatment requires the blood pump to operate at low blood flow rate (0.05–0.5 L/min). Given high blood trauma expected in these conditions, we sought secondly to investigate design improvements in order to reduce this risk.

Method

Computational fluid dynamics was used to analyze the blood fluid filled within the centrifugal pump and to estimate the blood trauma due to its operation. This assessment is based on the computation of integrated quantities such as the hemolysis index and the turbulent dissipation energy.

Results

The hemolysis index associated with the present device is comparable to the figures from HVAD. With the proposed pump, for instance, an index of 0.0036 is obtained at 1 L/min and 3000 rpm. Using thinner blades for the impeller allows a 12% reduction of the hemolysis index in average, while reducing its diameter leads to an index 2.8 folds lower at 0.5 L/min.

Conclusion

The present investigation shows the promising hemocompatibility of our centrifugal pump. Concerns about very high hemolysis generated at low flow rates could be overcome by reducing the impeller diameter. Experimental validations are planned to support our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesHeart FailureHemolysisHumansHydrodynamicsProsthesis DesignMaterials TestingModels, CardiovascularComputer SimulationCentrifugationEquipment Design

Stichwörter der Autor:innen

centrifugal pumphemolysisimpeller designturbulent dissipation energy

Autor:innen und Institutionen

  • Cnam, Arts et Metiers Institute of Technology, LIFSE, Paris, France.
  • Arts et Metiers Institute of Technology, Cnam, LIFSE, F-75013, Paris, France.
  • Department of Cardiovascular and Thoracic Surgery, Institute of Cardiology, Pitié Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris (AP-HP), Sorbonne University, Paris, France.

ORCID-Profile: Mathieu Specklin, Navideh Abbasnezhad

Zitieren

APA

Specklin, M., Marcel, L., Abbasnezhad, N., Bakir, F., Kouidri, S., & Danial, P. (2025). Improving the hemocompatibility of centrifugal mechanical circulatory support devices at low flow rates. Artificial Organs. https://doi.org/10.1111/aor.14899

Vancouver

Specklin M, Marcel L, Abbasnezhad N, Bakir F, Kouidri S, Danial P. Improving the hemocompatibility of centrifugal mechanical circulatory support devices at low flow rates. Artificial Organs. 2025. doi:10.1111/aor.14899

BibTeX
@article{Specklin2025,
  author = {Specklin, Mathieu and Marcel, Louis and Abbasnezhad, Navideh and Bakir, Farid and Kouidri, Smaine and Danial, Pichoy},
  title = {Improving the hemocompatibility of centrifugal mechanical circulatory support devices at low flow rates},
  journal = {Artificial Organs},
  year = {2025},
  doi = {10.1111/aor.14899}
}
Kostenlos starten →